(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC39A8 mRNA] CTD PMID:31150632 1,1-dichloroethene decreases expression ISO RGD:1317895 6480464 vinylidene chloride results in decreased expression of SLC39A8 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:1317895 6480464 1, 2-Dimethylhydrazine results in decreased expression of SLC39A8 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of SLC39A8 mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression ISO RGD:1317895 6480464 Ethinyl Estradiol results in increased expression of SLC39A8 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1317895 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC39A8 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1317895 6480464 Estradiol results in increased expression of SLC39A8 mRNA CTD PMID:15289156 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC39A8 mRNA CTD PMID:32741896 17beta-estradiol multiple interactions ISO RGD:1317894 6480464 [Estradiol co-treated with Progesterone] results in increased expression of SLC39A8 mRNA CTD PMID:20660070 17beta-estradiol increases expression ISO RGD:1317894 6480464 Estradiol results in increased expression of SLC39A8 mRNA CTD PMID:16474171 , PMID:19167446 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC39A8 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1317895 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC39A8 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1317895 6480464 Tetrachlorodibenzodioxin affects the expression of SLC39A8 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC39A8 mRNA CTD PMID:18796159 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1317895 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC39A8 mRNA CTD PMID:19933214 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SLC39A8 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of SLC39A8 mRNA CTD PMID:21346803 2-butoxyethanol increases expression ISO RGD:1317895 6480464 n-butoxyethanol results in increased expression of SLC39A8 mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:1317894 6480464 3 more ... CTD PMID:23146750 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1317894 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC39A8 mRNA CTD PMID:16997883 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of SLC39A8 mRNA CTD PMID:25380136 , PMID:30723492 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of SLC39A8 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of SLC39A8 mRNA CTD PMID:19483382 , PMID:24780913 8-Br-cAMP multiple interactions ISO RGD:1317894 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC39A8 mRNA CTD PMID:16997883 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC39A8 mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO RGD:1317895 6480464 Aflatoxin B1 results in decreased expression of SLC39A8 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1317894 6480464 Aflatoxin B1 results in decreased methylation of SLC39A8 gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO RGD:1317894 6480464 Tretinoin results in decreased expression of SLC39A8 mRNA CTD PMID:23724009 , PMID:33167477 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of SLC39A8 mRNA CTD PMID:19483382 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of SLC39A8 mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:1317894 6480464 Antirheumatic Agents results in decreased expression of SLC39A8 mRNA CTD PMID:24449571 arsane decreases expression ISO RGD:1317895 6480464 Arsenic results in decreased expression of SLC39A8 mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:1317895 6480464 Arsenic results in decreased expression of SLC39A8 mRNA CTD PMID:19654921 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of SLC39A8 mRNA CTD PMID:19483382 benzo[a]pyrene decreases expression ISO RGD:1317895 6480464 Benzo(a)pyrene results in decreased expression of SLC39A8 mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:1317894 6480464 Benzo(a)pyrene affects the methylation of SLC39A8 promoter CTD PMID:27901495 benzoates decreases expression ISO RGD:1317894 6480464 Benzoates analog results in decreased expression of SLC39A8 mRNA CTD PMID:29472718 beta-naphthoflavone decreases expression ISO RGD:1317894 6480464 beta-Naphthoflavone results in decreased expression of SLC39A8 mRNA CTD PMID:32858204 bisphenol A increases expression ISO RGD:1317894 6480464 bisphenol A results in increased expression of SLC39A8 mRNA CTD PMID:16474171 bisphenol A increases expression ISO RGD:1317895 6480464 bisphenol A results in increased expression of SLC39A8 mRNA CTD PMID:34585602 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC39A8 mRNA CTD PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC39A8 mRNA CTD PMID:25181051 Bisphenol B decreases expression ISO RGD:1317894 6480464 bisphenol B results in decreased expression of SLC39A8 mRNA CTD PMID:32387340 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of SLC39A8 mRNA CTD PMID:19167457 cadmium atom affects response to substance ISO RGD:1317895 6480464 SLC39A8 protein affects the susceptibility to Cadmium CTD PMID:16638970 cadmium atom affects uptake ISO RGD:1317894 6480464 SLC39A8 protein polymorphism affects the uptake of Cadmium CTD PMID:26102734 cadmium atom increases import EXP 6480464 SLC39A8 protein results in increased import of Cadmium CTD PMID:22898811 cadmium atom increases response to substance ISO RGD:1317895 6480464 SLC39A8 results in increased susceptibility to Cadmium CTD PMID:19194888 cadmium atom multiple interactions ISO RGD:1317894 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC39A8 mRNA more ... CTD PMID:18556457 more ... cadmium atom decreases expression ISO RGD:1317894 6480464 Cadmium results in decreased expression of SLC39A8 mRNA CTD PMID:18556457 cadmium atom multiple interactions ISO RGD:1317895 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC39A8 mRNA more ... CTD PMID:16638970 , PMID:33259630 cadmium atom increases uptake ISO RGD:1317895 6480464 SLC39A8 protein results in increased uptake of Cadmium CTD PMID:16638970 cadmium dichloride multiple interactions EXP 6480464 SLC39A8 protein affects the reaction [Sodium Bicarbonate results in increased uptake of Cadmium Chloride], zinc chloride inhibits the reaction [Cadmium Chloride results in increased expression of SLC39A8 mRNA] CTD PMID:21509381 , PMID:25653005 cadmium dichloride multiple interactions ISO RGD:1317895 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC39A8 mRNA CTD PMID:33259630 cadmium dichloride increases expression ISO RGD:1317894 6480464 Cadmium Chloride results in increased expression of SLC39A8 mRNA CTD PMID:23811327 , PMID:27647474 cadmium dichloride increases uptake EXP 6480464 SLC39A8 protein results in increased uptake of Cadmium Chloride CTD PMID:21509381 cadmium dichloride increases response to substance ISO RGD:1317895 6480464 SLC39A8 protein results in increased susceptibility to Cadmium Chloride CTD PMID:19699220 cadmium dichloride multiple interactions ISO RGD:1317894 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC39A8 mRNA more ... CTD PMID:18556457 more ... cadmium dichloride affects uptake ISO RGD:1317894 6480464 SLC39A8 affects the uptake of Cadmium Chloride CTD PMID:18556457 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SLC39A8 mRNA CTD PMID:25653005 calcitriol decreases expression ISO RGD:1317894 6480464 Calcitriol results in decreased expression of SLC39A8 mRNA CTD PMID:20089671 carbon nanotube decreases expression ISO RGD:1317895 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases expression ISO RGD:1317894 6480464 Nanotubes, Carbon results in increased expression of SLC39A8 mRNA CTD PMID:29348435 carbon nanotube increases expression ISO RGD:1317895 6480464 Nanotubes more ... CTD PMID:25554681 chloroprene decreases expression ISO RGD:1317895 6480464 Chloroprene results in decreased expression of SLC39A8 mRNA CTD PMID:23125180 chlorpyrifos affects expression ISO RGD:1317895 6480464 Chlorpyrifos affects the expression of SLC39A8 mRNA CTD PMID:32715474 cisplatin increases response to substance ISO RGD:1317895 6480464 SLC39A8 protein results in increased susceptibility to Cisplatin CTD PMID:30342059 cisplatin multiple interactions ISO RGD:1317894 6480464 [SLC39A8 protein affects the susceptibility to Cisplatin] which affects the cleavage of CASP3 protein more ... CTD PMID:30342059 cisplatin multiple interactions ISO RGD:1317895 6480464 [SLC39A8 protein results in increased susceptibility to Cisplatin] which results in decreased expression of BCL2 protein more ... CTD PMID:30342059 cisplatin affects response to substance ISO RGD:1317894 6480464 SLC39A8 protein affects the susceptibility to Cisplatin CTD PMID:30342059 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of SLC39A8 mRNA CTD PMID:19483382 cobalt atom multiple interactions EXP 6480464 Cobalt inhibits the reaction [SLC39A8 protein results in increased import of Iron] CTD PMID:22898811 cobalt atom increases import EXP 6480464 SLC39A8 protein results in increased import of Cobalt CTD PMID:22898811 copper atom increases expression EXP 6480464 Copper results in increased expression of SLC39A8 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of SLC39A8 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO RGD:1317894 6480464 Copper Sulfate results in decreased expression of SLC39A8 mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:1317894 6480464 Coumestrol results in increased expression of SLC39A8 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1317894 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:1317894 6480464 Cyclosporine results in decreased expression of SLC39A8 mRNA CTD PMID:22147139 dexamethasone multiple interactions ISO RGD:1317894 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC39A8 mRNA CTD PMID:16997883 dextran sulfate multiple interactions ISO RGD:1317895 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC39A8 mRNA CTD PMID:29950665 diethylstilbestrol increases expression ISO RGD:1317895 6480464 Diethylstilbestrol results in increased expression of SLC39A8 mRNA CTD PMID:15289156 diuron decreases expression EXP 6480464 Diuron results in decreased expression of SLC39A8 mRNA CTD PMID:21551480 , PMID:25152437 dorsomorphin multiple interactions ISO RGD:1317894 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1317894 6480464 Doxorubicin results in decreased expression of SLC39A8 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SLC39A8 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1317894 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC39A8 mRNA CTD PMID:19167446 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC39A8 mRNA CTD PMID:24136188 genistein increases expression ISO RGD:1317894 6480464 Genistein results in increased expression of SLC39A8 mRNA CTD PMID:16474171 genistein increases expression ISO RGD:1317895 6480464 Genistein results in increased expression of SLC39A8 mRNA CTD PMID:15289156 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC39A8 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of SLC39A8 mRNA CTD PMID:24136188 hydrogencarbonate multiple interactions ISO RGD:1317895 6480464 Bicarbonates promotes the reaction [SLC39A8 protein results in increased uptake of Cadmium], SLC39A8 protein results in increased uptake of [Manganese co-treated with Bicarbonates] CTD PMID:16638970 iron atom multiple interactions ISO RGD:1317895 6480464 Protons affects the reaction [SLC39A8 protein results in increased import of Iron] CTD PMID:22898811 iron atom increases import ISO RGD:1317894 6480464 SLC39A8 protein results in increased import of Iron CTD PMID:22898811 iron atom increases import EXP 6480464 SLC39A8 protein results in increased import of Iron CTD PMID:22898811 iron atom multiple interactions EXP 6480464 Cobalt inhibits the reaction [SLC39A8 protein results in increased import of Iron] more ... CTD PMID:22898811 iron atom increases import ISO RGD:1317895 6480464 SLC39A8 protein results in increased import of Iron CTD PMID:22898811 iron(0) increases import ISO RGD:1317895 6480464 SLC39A8 protein results in increased import of Iron CTD PMID:22898811 iron(0) increases import ISO RGD:1317894 6480464 SLC39A8 protein results in increased import of Iron CTD PMID:22898811 iron(0) multiple interactions ISO RGD:1317895 6480464 Protons affects the reaction [SLC39A8 protein results in increased import of Iron] CTD PMID:22898811 iron(0) increases import EXP 6480464 SLC39A8 protein results in increased import of Iron CTD PMID:22898811 iron(0) multiple interactions EXP 6480464 Cobalt inhibits the reaction [SLC39A8 protein results in increased import of Iron] more ... CTD PMID:22898811 isotretinoin decreases expression ISO RGD:1317894 6480464 Isotretinoin results in decreased expression of SLC39A8 mRNA CTD PMID:20436886 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of SLC39A8 mRNA CTD PMID:19483382 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of SLC39A8 mRNA CTD PMID:22641619 lead diacetate decreases expression ISO RGD:1317895 6480464 lead acetate results in decreased expression of SLC39A8 mRNA CTD PMID:22613225 manganese atom multiple interactions ISO RGD:1317895 6480464 Manganese inhibits the reaction [SLC39A8 protein results in increased uptake of Cadmium], SLC39A8 protein results in increased uptake of [Manganese co-treated with Bicarbonates] CTD PMID:16638970 manganese atom increases import EXP 6480464 SLC39A8 protein results in increased import of Manganese CTD PMID:22898811 manganese atom multiple interactions EXP 6480464 Manganese inhibits the reaction [SLC39A8 protein results in increased import of Iron] CTD PMID:22898811 manganese atom affects transport ISO RGD:1317894 6480464 SLC39A8 gene SNP affects the transport of Manganese, SLC39A8 SNP affects the transport of Manganese CTD PMID:26025379 , PMID:28917719 manganese atom increases uptake ISO RGD:1317895 6480464 SLC39A8 protein results in increased uptake of Manganese CTD PMID:16638970 manganese(0) multiple interactions ISO RGD:1317895 6480464 Manganese inhibits the reaction [SLC39A8 protein results in increased uptake of Cadmium], SLC39A8 protein results in increased uptake of [Manganese co-treated with Bicarbonates] CTD PMID:16638970 manganese(0) increases import EXP 6480464 SLC39A8 protein results in increased import of Manganese CTD PMID:22898811 manganese(0) multiple interactions EXP 6480464 Manganese inhibits the reaction [SLC39A8 protein results in increased import of Iron] CTD PMID:22898811 manganese(0) affects transport ISO RGD:1317894 6480464 SLC39A8 gene SNP affects the transport of Manganese, SLC39A8 SNP affects the transport of Manganese CTD PMID:26025379 , PMID:28917719 manganese(0) increases uptake ISO RGD:1317895 6480464 SLC39A8 protein results in increased uptake of Manganese CTD PMID:16638970 manganese(II) chloride increases uptake EXP 6480464 SLC39A8 protein results in increased uptake of manganese chloride CTD PMID:21509381 manganese(II) chloride multiple interactions EXP 6480464 SLC39A8 protein affects the reaction [Sodium Bicarbonate results in increased uptake of manganese chloride] CTD PMID:21509381 mercury atom multiple interactions ISO RGD:1317895 6480464 Mercury inhibits the reaction [SLC39A8 protein results in increased uptake of Cadmium] CTD PMID:16638970 mercury dibromide increases expression ISO RGD:1317894 6480464 mercuric bromide results in increased expression of SLC39A8 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1317894 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC39A8 mRNA CTD PMID:27188386 mercury(0) multiple interactions ISO RGD:1317895 6480464 Mercury inhibits the reaction [SLC39A8 protein results in increased uptake of Cadmium] CTD PMID:16638970 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of SLC39A8 mRNA CTD PMID:30467583 methotrexate affects expression ISO RGD:1317895 6480464 Methotrexate affects the expression of SLC39A8 mRNA CTD PMID:18502557 methylmercury chloride increases expression ISO RGD:1317894 6480464 methylmercuric chloride results in increased expression of SLC39A8 mRNA CTD PMID:26272509 N-methylformamide increases expression ISO RGD:1317895 6480464 methylformamide analog results in increased expression of SLC39A8 mRNA, methylformamide results in increased expression of SLC39A8 mRNA CTD PMID:17040096 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of SLC39A8 mRNA CTD PMID:25380136 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of SLC39A8 mRNA CTD PMID:24136188 nickel atom increases expression ISO RGD:1317894 6480464 Nickel results in increased expression of SLC39A8 mRNA CTD PMID:24768652 , PMID:25583101 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of SLC39A8 mRNA CTD PMID:24136188 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of SLC39A8 mRNA CTD PMID:33484710 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of SLC39A8 mRNA CTD PMID:19483382 panobinostat multiple interactions ISO RGD:1317894 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC39A8 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1317894 6480464 panobinostat results in increased expression of SLC39A8 mRNA CTD PMID:26272509 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC39A8 mRNA CTD PMID:33387578 phenobarbital affects expression ISO RGD:1317894 6480464 Phenobarbital affects the expression of SLC39A8 mRNA CTD PMID:19159669 phenobarbital affects expression ISO RGD:1317895 6480464 Phenobarbital affects the expression of SLC39A8 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1317894 6480464 Phenylmercuric Acetate results in increased expression of SLC39A8 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1317894 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC39A8 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1317895 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC39A8 mRNA CTD PMID:19710929 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of SLC39A8 mRNA CTD PMID:22484513 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of SLC39A8 mRNA CTD PMID:19483382 potassium cyanide multiple interactions ISO RGD:1317895 6480464 Potassium Cyanide inhibits the reaction [SLC39A8 protein results in increased uptake of Cadmium] CTD PMID:16638970 progesterone multiple interactions ISO RGD:1317894 6480464 [Estradiol co-treated with Progesterone] results in increased expression of SLC39A8 mRNA CTD PMID:20660070 propanal increases expression ISO RGD:1317894 6480464 propionaldehyde results in increased expression of SLC39A8 mRNA CTD PMID:26079696 quercitrin decreases expression ISO RGD:1317894 6480464 quercitrin results in decreased expression of SLC39A8 mRNA CTD PMID:25193878 resveratrol multiple interactions ISO RGD:1317894 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of SLC39A8 mRNA CTD PMID:19167446 rimonabant multiple interactions ISO RGD:1317895 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of SLC39A8 mRNA] CTD PMID:19030233 SB 431542 multiple interactions ISO RGD:1317894 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite decreases expression ISO RGD:1317894 6480464 sodium arsenite results in decreased expression of SLC39A8 protein CTD PMID:21925251 sodium arsenite increases expression ISO RGD:1317894 6480464 sodium arsenite results in increased expression of SLC39A8 mRNA CTD PMID:22714537 sodium hydrogencarbonate multiple interactions EXP 6480464 SLC39A8 protein affects the reaction [Sodium Bicarbonate results in increased uptake of Cadmium Chloride], SLC39A8 protein affects the reaction [Sodium Bicarbonate results in increased uptake of manganese chloride] CTD PMID:21509381 Soman decreases expression EXP 6480464 Soman results in decreased expression of SLC39A8 mRNA CTD PMID:19281266 sunitinib increases expression ISO RGD:1317894 6480464 Sunitinib results in increased expression of SLC39A8 mRNA CTD PMID:31533062 testosterone increases expression ISO RGD:1317895 6480464 Testosterone deficiency results in increased expression of SLC39A8 mRNA CTD PMID:33848595 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC39A8 mRNA CTD PMID:32741896 testosterone multiple interactions ISO RGD:1317895 6480464 1 more ... CTD PMID:33848595 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC39A8 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:1317895 6480464 Carbon Tetrachloride results in decreased expression of SLC39A8 mRNA CTD PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC39A8 mRNA CTD PMID:31150632 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of SLC39A8 mRNA CTD PMID:19483382 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC39A8 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1317895 6480464 titanium dioxide results in increased expression of SLC39A8 mRNA CTD PMID:29264374 titanium dioxide multiple interactions ISO RGD:1317895 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC39A8 mRNA CTD PMID:29950665 toluene increases expression EXP 6480464 Toluene results in increased expression of SLC39A8 mRNA CTD PMID:22967744 topotecan affects response to substance ISO RGD:1317894 6480464 SLC39A8 protein affects the susceptibility to Topotecan CTD PMID:16217747 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of SLC39A8 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1317894 6480464 trichostatin A results in increased expression of SLC39A8 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1317894 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC39A8 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1317894 6480464 Triclosan results in decreased expression of SLC39A8 mRNA CTD PMID:30510588 triptonide increases expression ISO RGD:1317895 6480464 triptonide results in increased expression of SLC39A8 mRNA CTD PMID:33045310 valproic acid affects expression ISO RGD:1317894 6480464 Valproic Acid affects the expression of SLC39A8 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1317894 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC39A8 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1317894 6480464 Valproic Acid results in increased expression of SLC39A8 mRNA CTD PMID:23179753 more ... vancomycin increases expression ISO RGD:1317895 6480464 Vancomycin results in increased expression of SLC39A8 mRNA CTD PMID:18930951 vorinostat multiple interactions ISO RGD:1317894 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC39A8 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1317894 6480464 vorinostat results in increased expression of SLC39A8 mRNA CTD PMID:26272509 zinc atom increases transport ISO RGD:1317894 6480464 SLC39A8 protein results in increased transport of Zinc CTD PMID:18326752 zinc atom increases expression EXP 6480464 Zinc results in increased expression of SLC39A8 protein CTD PMID:22898811 zinc atom increases import EXP 6480464 SLC39A8 protein results in increased import of Zinc CTD PMID:22898811 zinc atom multiple interactions EXP 6480464 Iron inhibits the reaction [SLC39A8 protein results in increased import of Zinc], Zinc inhibits the reaction [SLC39A8 protein results in increased import of Iron] CTD PMID:22898811 zinc atom multiple interactions ISO RGD:1317894 6480464 [TNF protein results in increased expression of SLC39A8 protein] which results in increased import of Zinc CTD PMID:18390834 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of SLC39A8 mRNA CTD PMID:20859692 zinc atom decreases expression ISO RGD:1317895 6480464 Zinc results in decreased expression of SLC39A8 mRNA CTD PMID:17085522 zinc dichloride multiple interactions EXP 6480464 zinc chloride inhibits the reaction [Cadmium Chloride results in increased expression of SLC39A8 mRNA] CTD PMID:25653005 zinc(0) increases transport ISO RGD:1317894 6480464 SLC39A8 protein results in increased transport of Zinc CTD PMID:18326752 zinc(0) decreases expression ISO RGD:1317895 6480464 Zinc results in decreased expression of SLC39A8 mRNA CTD PMID:17085522 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of SLC39A8 mRNA CTD PMID:20859692 zinc(0) multiple interactions ISO RGD:1317894 6480464 [TNF protein results in increased expression of SLC39A8 protein] which results in increased import of Zinc CTD PMID:18390834 zinc(0) increases import EXP 6480464 SLC39A8 protein results in increased import of Zinc CTD PMID:22898811 zinc(0) multiple interactions EXP 6480464 Iron inhibits the reaction [SLC39A8 protein results in increased import of Zinc], Zinc inhibits the reaction [SLC39A8 protein results in increased import of Iron] CTD PMID:22898811 zinc(0) increases expression EXP 6480464 Zinc results in increased expression of SLC39A8 protein CTD PMID:22898811 zoledronic acid increases expression ISO RGD:1317894 6480464 zoledronic acid results in increased expression of SLC39A8 mRNA CTD PMID:24714768